Ocugen Makes Breakthroughs in Q1 2025: Advancing Gene Therapy Frontiers
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced its financial results for the first quarter…
biotech & biomedical, biotechnology, healthcare and medicine, medicine and healthcare, News
0